RU94038588A - Method of secondary immunodeficiency treatment
- Google Patents
Method of secondary immunodeficiency treatment
Info
Publication number
RU94038588A
RU94038588ARU94038588/14ARU94038588ARU94038588ARU 94038588 ARU94038588 ARU 94038588ARU 94038588/14 ARU94038588/14 ARU 94038588/14ARU 94038588 ARU94038588 ARU 94038588ARU 94038588 ARU94038588 ARU 94038588A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт клинической иммунологии СО РАМНfiledCriticalИнститут клинической иммунологии СО РАМН
Priority to RU94038588ApriorityCriticalpatent/RU2099051C1/en
Publication of RU94038588ApublicationCriticalpatent/RU94038588A/en
Application grantedgrantedCritical
Publication of RU2099051C1publicationCriticalpatent/RU2099051C1/en
FIELD: medicine, viral hepatitis B. SUBSTANCE: method involves the use of trecrezan (dose is 0.1-10 mg/kg/day for 3 doses for 2-3 weeks) for patient treatment with acute viral infection beginning from period of maximal hepatitis B virus replication. EFFECT: expressed sanogenetic action.
Claims (1)
Изобретение относится к способам лечения лекарственными препаратами ВИД у часто и длительно болеющих, и при остром вирусном гепатите В. Задача изобретения - повышение эффективности лечения. Сущность изобретения: при способе лечения ВИД вследствие острой вирусной инфекции и у часто и длительно болеющих, включающем иммунологическое обследование и обследование на наличие маркеров репликации вируса, больному вводят трекрезан по 0,1 - 10 мг/кг/сутки в 3 приема в течение 2-3 недель, начиная с периода максимальной репликации вируса. Использование способа обеспечивает выраженный саногенетический эффект.The invention relates to methods for treating VID with often and long-term ill patients, and with acute viral hepatitis B. The objective of the invention is to increase the effectiveness of treatment. The inventive method for the treatment of VID due to acute viral infection and often sick for a long time, including immunological examination and examination for the presence of markers of replication of the virus, the patient is administered trekrezan at 0.1 - 10 mg / kg / day in 3 divided doses for 2- 3 weeks starting from the period of maximum virus replication. Using the method provides a pronounced sanogenetic effect.
RU94038588A1994-10-141994-10-14Method for treating secondary immunodeficiency
RU2099051C1
(en)
Vaccine against hepatitis containing 3-o-deacylated monophosphoryl-lipid a, use of hepatitis antigen for preparing the preparation for hepatitis treatment, method of hepatitis treatment
The Slow, Insidious Natures of the HTLV's: The scope of the viruses that cause AIDS and certain leukemias and lymphomas is broadening in terms of number of people affected and range of clinical syndromes